MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More…
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
Phone703-251-8500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.39 billion
Profitability
Miscellaneous
Employees18,600
Next Earnings Date11/19/2019 (Estimated)
OptionableOptionable
MAXIMUS (NYSE:MMS) Frequently Asked Questions
What is MAXIMUS's stock symbol?
MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."
How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?
MAXIMUS declared a quarterly dividend on Wednesday, July 10th. Shareholders of record on Thursday, August 15th will be paid a dividend of $0.25 per share on Friday, August 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date is Wednesday, August 14th. View MAXIMUS's Dividend History.
How will MAXIMUS's stock buyback program work?
MAXIMUS declared that its board has approved a share buyback program on Monday, June 25th 2018, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 4.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its shares are undervalued.
How were MAXIMUS's earnings last quarter?
MAXIMUS, Inc. (NYSE:MMS) released its quarterly earnings data on Thursday, August, 8th. The health services provider reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. The health services provider earned $730.70 million during the quarter, compared to the consensus estimate of $754.81 million. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. MAXIMUS's quarterly revenue was up 22.2% on a year-over-year basis. During the same period last year, the business posted $0.91 EPS. View MAXIMUS's Earnings History.
When is MAXIMUS's next earnings date?
What guidance has MAXIMUS issued on next quarter's earnings?
MAXIMUS updated its FY19 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of $3.70-3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.70. The company issued revenue guidance of $2.92 billion, compared to the consensus revenue estimate of prior $3.65-3.75.
What price target have analysts set for MMS?
2 brokerages have issued 1-year target prices for MAXIMUS's shares. Their predictions range from $77.00 to $83.00. On average, they expect MAXIMUS's share price to reach $80.00 in the next twelve months. This suggests a possible upside of 0.6% from the stock's current price. View Analyst Price Targets for MAXIMUS.
What is the consensus analysts' recommendation for MAXIMUS?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.
Has MAXIMUS been receiving favorable news coverage?
News articles about MMS stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. MAXIMUS earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave news coverage about the health services provider a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for MAXIMUS.
Are investors shorting MAXIMUS?
MAXIMUS saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,613,100 shares, an increase of 14.6% from the July 31st total of 1,407,300 shares. Based on an average daily volume of 284,400 shares, the short-interest ratio is currently 5.7 days. Approximately 2.6% of the shares of the stock are sold short. View MAXIMUS's Current Options Chain.
Who are some of MAXIMUS's key competitors?
Some companies that are related to MAXIMUS include Ctrip.Com International (CTRP), Msci (MSCI), Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), LYFT (LYFT), The Western Union (WU), Fair Isaac (FICO), WEX (WEX), Nielsen (NLSN), Etsy (ETSY), Alliance Data Systems (ADS), Zillow Group (ZG), Zillow Group (Z), GrubHub (GRUB) and CDK Global (CDK).
What other stocks do shareholders of MAXIMUS own?
Who are MAXIMUS's key executives?
MAXIMUS's management team includes the folowing people:
- Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
- Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
- Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
- Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
- Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)
Who are MAXIMUS's major shareholders?
MAXIMUS's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.49%), BlackRock Inc. (11.49%), Vanguard Group Inc. (10.95%), Victory Capital Management Inc. (6.29%), Mackenzie Financial Corp (2.73%) and Van Berkom & Associates Inc. (2.03%). Company insiders that own MAXIMUS stock include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.
Which major investors are selling MAXIMUS stock?
MMS stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, Prudential Financial Inc., Panagora Asset Management Inc., AQR Capital Management LLC, Bank of New York Mellon Corp, Janus Henderson Group PLC and Janus Henderson Group PLC. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.
Which major investors are buying MAXIMUS stock?
MMS stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Nuveen Asset Management LLC, DekaBank Deutsche Girozentrale, William Blair Investment Management LLC, Skandinaviska Enskilda Banken AB publ, AXA, UBS Asset Management Americas Inc. and Mondrian Investment Partners LTD. View Insider Buying and Selling for MAXIMUS.
How do I buy shares of MAXIMUS?
Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is MAXIMUS's stock price today?
One share of MMS stock can currently be purchased for approximately $79.49.
How big of a company is MAXIMUS?
MAXIMUS has a market capitalization of $5.07 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.View Additional Information About MAXIMUS.
What is MAXIMUS's official website?
How can I contact MAXIMUS?
MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]
MarketBeat Community Rating for MAXIMUS (NYSE MMS)
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
